Samit Hirawat
Förmögenhet: 2 M $ per 2026-06-30
Förmögenhet: 2 M $ per 2026-06-30
Samit Hirawat is currently an Independent Director at Pacira Biosciences, Inc. starting in 2026.
Formerly, Dr. Hirawat was Chief Medical Officer-Global Drug Development at Bristol Myers Squibb Co. from 2019 to 2025 and Head- Global Oncology Development at Novartis AG from 2017 to 2019.
Education includes an undergraduate degree from SMS Medical College & Hospital.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-03-12 | 31 925 ( 0 % ) | 2 M $ | 2026-06-30 | |
PACIRA BIOSCIENCES, INC. 0,02 % | 2026-06-10 | 6 405 ( 0,02 % ) | 162 495 $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| PACIRA BIOSCIENCES, INC. | Direktör/Styrelseledamot | 2026-01-27 |
| Företag | Position | Slut |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Teknisk/Vetenskaplig/F&U Direktör | 2025-08-01 |
| NOVARTIS AG | Företagsledare/Principal | 2019-06-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Pacira Biosciences, Inc.
Pacira Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures injectable therapeutic products | Health Technology |
SMS Medical College & Hospital
SMS Medical College & Hospital Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån